A transgenic mouse line that expresses iCre under regulation of the Cytochrome P 450 17α-hydroxylase/17, 20-lyase (Cyp17) promoter was developed as a novel transgenic mouse model for the conditional deletion of genes specifically in the theca/interstitial cells of the ovary and Leydig cells of the testis. In this report we describe the development of Cyp17iCre mice and the application of these mice for conditional deletion of the estrogen receptor alpha (Esr1) gene in the theca/ interstitial and Leydig cells of the female and male gonad, respectively. These mice will prove a powerful tool to inactivate genes in the gonad in a cell-specific manner.Targeted gene deletion has become a powerful tool in the study of gene function with the utilization of this technology leading to marked progress in our understanding of both physiological and pathophysiological systems. The ovary is one organ where targeted genetic deletion has proven fruitful with the establishment of transgenic mice with Cre expression targeted to granulosa cells (Lécureuil et al., 2002), somatic cells (Bingham et al., 2006) and the oocyte (Lan et al., 2004;Lewandoski et al., 1997). However, our understanding of ovarian function cannot advance at optimal pace without a tool to specifically delete genes of interest from the other major endocrine cell population of the ovary, the theca/interstitial cells. Hence, our primary goal was to develop the mice necessary to allow the specific deletion of genes in the theca/interstitial cells of the ovary and in this report we describe the generation of such a line of transgenic mice, with codon-improved Cre (iCre) driven by the promoter to Cytochrome P 450 17α-hydroxylase/17, 20-lyase (Cyp17).Cytochrome P 450 17α-hydroxylase/17, 20-lyase, the product of Cyp17 gene expression, plays a major role in the control of sex steroid hormone synthesis by mediating the17α-hydroxylation of pregnenolone or progesterone to dehydroepiandrostenedione or androstenedione, respectively. In the female mouse, Cyp17 expression is primarily restricted to the ovary and placenta (Su et al., 2002) and within the ovary, Cyp17 is abundant in the gonadotropin-primed theca/interstitial cell population, but not the granulosa cells or oocyte (Zhang et al., 2001), making it ideal for iCre targeting. Furthermore, coincident to the need of a transgenic mouse line with iCre targeted to the theca/interstitial cells, is one also designed to allow the deletion of Leydig cell specific genes from the male gonad. Fortunately, the specificity of Cyp17 expression to the Leydig cells of the testis (Zhang et al., 2001) makes this line of mice also ideal as a tool to inactive genes specifically within that endocrine population of cells. Hence, this report was widened as a functional characterization of these mice inclusive to both the sexes.Three lines of Cyp17iCre founder mice were generated (A, B and C) by pronuclear injection of a KpnI/SalI DNA fragment derived from a Cyp17iCre expression plasmid (Figure 1). Then, to facilitate expression analys...